地点: 美国 发布时间:2013-09-21 21:21:02 |
Motivated individuals with experience in molecular virology and angiogenesis targeting are required to join the group of Dr. Kah-Whye Peng to develop replication-competent oncolytic measles viruses for cancer therapy with particular emphasis on retargeting virus tropism to tumor neovasculature.
Salary will be determined by the successful candidate’s experience. There is an attractive benefit package. Mayo Clinic Rochester is a not-for-profit organization. Mayo integrates research with clinical practice and education in a multi-campus environment.
Applications, including curriculum vitae and bibliography, summary of past accomplishments, and the names and email addresses of three references, should be emailed to:
Kah-Whye Peng, Ph.D. (peng.kah@mayo.edu)
|
|
|
|
|
|
|
|
|
